A drop in the number of sites offering mammography may be partially to blame for a decline in mammography volume over the last eight years. An IMV Medical Information report on U.S. mammography centers has noted a 16% decline in the number of x-ray breast exams from 43.9 million procedures in 2000 to 36.7 million last year. The number of government-certified mammography centers dropped 16% over this period, from 9910 sites as of May 2000 to 8670 sites as of December 2007. The drop in procedure volume appears to have been steady since 2000, according to the market research firm.
It was over almost before it started. A shareholder class action lawsuit filed in the Superior Court of Suffolk County, MA, on March 11 alleged, among other things, that the Emageon board of directors violated its fiduciary duties by not maximizing value for the company's shareholders when entering into the planned merger Feb. 23 with Amicas. But the suit didn't last long. The plaintiff withdrew the complaint five days later, according to an 8-K filing with the Securities and Exchange Commission.
More than 10,000 licenses have been issued worldwide by TeraRecon for the use of its Aquarius advanced visualization technology. The milestone gives provides bragging rights for the greatest market share in the direct-to-end-user market for advanced visualization, according to the company.
Study: Mammography AI Leads to 29 Percent Increase in Breast Cancer Detection
February 5th 2025Use of the mammography AI software had a nearly equivalent false positive rate as unassisted radiologist interpretation and resulted in a 44 percent reduction in screen reading workload, according to findings from a randomized controlled trial involving over 105,000 women.
Can AI Bolster Breast Cancer Detection in DBT Screening?
January 16th 2025In sequential breast cancer screening with digital breast tomosynthesis (DBT), true positive examinations had more than double the AI case score of true negative examinations and the highest positive AI score changes from previous exams, according to new research.
Mammography Study Suggests DBT-Based AI May Help Reduce Disparities with Breast Cancer Screening
December 13th 2024New research suggests that AI-powered assessment of digital breast tomosynthesis (DBT) for short-term breast cancer risk may help address racial disparities with detection and shortcomings of traditional mammography in women with dense breasts.
Mammography News: FDA Grants Expanded 510(k) Clearance for AI-Powered SmartMammo Dx DBT Software
November 29th 2024Originally cleared by the FDA in 2021, the SmartMammo Dx software for digital breast tomosynthesis (DBT) can now be utilized with the Senographe Pristina mammography systems from GE HealthCare.